The Effect of Ketorolac On Posterior Minimally Invasive Lumbar Spinal Fusion

Lead Author, Chad F. Claus, DO, discusses his recent TSJ Outstanding Paper: The Effect of Ketorolac On Posterior Minimally Invasive Lumbar Spinal Fusion: An Interim Analysis from a Randomized, Double-Blinded, Placebo-Controlled Trial with Moderator Tejas Shah, MD.

Access the article here: https://www.spineline-digital.org/spineline/november_december_2021/MobilePagedReplica.action?pm=2&folio=20#pg22

Disclosures:

Claus, Chad: Nothing to Disclose

Shah, Tejas: Nothing to Disclose

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+